Australia’s Largest Christian News Site

An increasing number of studies show us how Australia can escape lockdowns: by treating Covid patients early with a triple therapy of Ivermectin, Doxycycline and Zinc.

Ivermectin, Doxycycline and Zinc have been recommended as critical components of triple therapy against Covid by medical experts worldwide. Those who have recommended the treatment include the British Ivermectin Recommendation Development (BIRD) panel and the Front Line Covid Critical Care (FLCCC) alliance based in Washington DC.

It has also been recommended by Australia’s own globally renowned Professor Thomas Borody, who developed
triple therapy for Helicobacter Pylori infection, and is now regarded as the world’s foremost expert in triple therapy.

Indeed, a TGA submission has been prepared for Ivermectin combination therapy to be used in the early treatment phase of Covid. The triple therapy is supported by two seminal papers recently published in The American Journal of Therapeutics regarding large meta-analyses of multiple Ivermectin trials.

The first of these, entitled Ivermectin for Prevention and Treatment of COVID-19 Infection, states:

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using Ivermectin. Using Ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that Ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

Moreover, the study asserts that “the findings indicate with moderate certainty that ivermectin treatment in COVID-19 provides a significant survival benefit.”

The second paper is a Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19, which the reader is encouraged to peruse.

Further Studies on the Efficacy of Triple Therapy

Another recent paper establishing the efficacy of triple therapy is Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19, published in the New Microbes and New Infections journal. Released this month, the study says:

In summary, based on the totality of the trials and epidemiologic evidence presented in this review along with the preliminary findings of the Unitaid/WHO meta-analysis of treatment RCTs and the guideline recommendation from the international BIRD conference, Ivermectin should be globally and systematically deployed in the prevention and treatment of COVID-19.

In the real world, cases and deaths in Peru, Slovakia and Zimbabwe subsided where Ivermectin was freely distributed, and the same phenomenon has been repeated in India more recently. States such as Goa that adopted mass distribution of Ivermectin crushed their cases; those that refused it, such as Tamil Nadu, didn’t.

These events prompted the Indian Bar Association to serve legal notices upon the chief scientist of the WHO, Dr Soumya Swaminathan, an Indian national, and WHO Director-General Dr Tedros, accusing them of “contempt of court and aggravated offences against humanity by spreading disinformation on Ivermectin.”

Medical Associations have also advocated Ivermectin use in Japan.

Former Vice Chief of Internal Medicine at Baylor University Professor Peter McCullough and Dr Vladimir Zelenko of New York (who has treated well over 6,000 Covid-19 sufferers) estimate that hospitalisations can be reduced by greater than 80 per cent for sufferers of Covid-19.

Their proposal: that patients are treated at the earliest possible opportunity with combination therapies involving Ivermectin, Zinc, Doxycycline, and an anticoagulant appropriate for the sufferer’s medical circumstances. If sufferers were treated as soon as symptoms present with these therapeutics, the IFR of Covid-19, including variants, could be far less than that seen with Influenza.

Last but not least, to quote Professor Robert Clancy, one of the most senior clinical immunologists in Australia and an expert in autoimmune disease, immunisation and mucosal inflammatory disease:

Making Ivermectin available across the Covid community now will shorten the current community crises where infection is out of control, will be synergistic with the vaccine programme facilitating movement through the planned stages, and greatly facilitate our reconnect with the world outside the bubble.

The question almost every experienced clinician is asking in Australia is, “we have a problem that we are doing nothing for, one that is threatening the very fibre of our nation, and vaccines are looking a little iffy.

There is a drug available for early treatment of Covid-19 with more evidence supporting its safety and efficacy than there is for most drugs I use every day. Why are we not using this drug? What on earth has my patient got to lose? Where is the leadership?

Our Missing Link to Ending Lockdowns

As a direct result of lockdowns, I have witnessed delayed cancer diagnosis, the detrimental effects of delayed surgeries and medical appointments, increased mental health issues and suicides, domestic violence, and a deterioration of chronic health conditions such as diabetes and cardiovascular diseases. Not only this: I have also seen social and family fragmentation through the loss of our civil liberties.

We are witnessing increased and understandable social unrest with police using extreme brutality in enforcing draconian rules for an unachievable goal of viral elimination. Moreover, we are using vaccines that incorporate technologies that have never previously been used in human beings in large numbers and that have unknown long-term consequences.

Australia’s governments can expedite the lifting of lockdown restrictions if we use Ivermectin, Doxycycline and Zinc in triple therapy. If patients receive early treatment with this protocol, we will see reductions in infections, hospital admissions, morbidity, long covid, and mortality.

One of Australia’s most distinguished academics, Professor Ramesh Thakur, former Assistant Secretary-General of the United Nations, recommends that to escape the lockdowns and other measures which are causing enormous harms, we should do the following:

1. Set a hard target date for vaccines (non-mandatory) to be offered to all adults
2. Proclaim in advance the end of all restrictions throughout Australia on that date. Those fully vaccinated are better protected against infections and, if infected, against the severity of illness. Those who have chosen not to be vaccinated are solely responsible for their decision and its consequences for their health, but no more likely than the vaccinated to spread the virus.
3. Announce that based on everything we now know about transmissibility and breakthrough infections, especially by new variants, domestic vaccination certificates are pointless and will not be required for any purpose
4. Terminate testing and contact tracing for asymptomatic people. It sustains a state of fear without serving any useful medical purpose.
5. Issue clear and coherent guidelines on voluntary best practice personal hygiene and social interactions to reduce spread. This should include rapid testing with the onset of symptoms and isolation following clinical diagnosis.
6. Loosen international travel but require rigorous protocols, including inexpensive and quick-results testing
7. Invest in high-quality assessments of the efficacy of newly developed and repurposed early treatment drugs
8. Invest in a substantial upgrade of the health, hospital and ICU infrastructure at the national level, with clear protocols for moving patients as required from infection hotspots to where there is spare capacity with guaranteed open state borders.

As I stated in my previous article, the time for us to act is now. We are moving into dangerous territory. Together, we can help reduce the immense fear, suffering, health deterioration, and lockdowns in our nation by providing sane, safe, and practical solutions. It’s time to lead with hope, not fear.